BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36739345)

  • 1. The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species.
    Watanabe J; Ihara H; Takei S; Nakamura A; Fujimoto Y; Handoh T; Kurokawa K; Arai Y; Shibayama K; Sumiyoshi I; Ochi Y; Okabe T; Misawa S; Togo S; Naito T; Tabe Y; Miida T; Takahashi K
    Sci Rep; 2023 Feb; 13(1):2027. PubMed ID: 36739345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
    Kamada K; Yoshida A; Iguchi S; Arai Y; Uzawa Y; Konno S; Shimojima M; Kikuchi K
    Sci Rep; 2021 Jun; 11(1):12208. PubMed ID: 34108590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
    Ruedas-López A; Tato M; Broncano-Lavado A; Esteban J; Ruiz-Serrano MJ; Sánchez-Cueto M; Toro C; Domingo D; Cacho J; Barrado L; López-Roa P
    Microbiol Spectr; 2023 Jun; 11(3):e0504122. PubMed ID: 37212700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report.
    Akiyama Y; Iwamoto N; Kamada K; Yoshida A; Osugi A; Mitarai S; Suzuki T; Yamamoto K; Nagashima M; Horai T; Ohmagari N
    BMC Infect Dis; 2023 Oct; 23(1):694. PubMed ID: 37848843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
    J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
    Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
    Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massiliense.
    Oka K; Morioka H; Eguchi M; Sato Y; Tetsuka N; Iguchi M; Kanematsu T; Fukano H; Hoshino Y; Kiyoi H; Yagi T
    Intern Med; 2021 Sep; 60(18):3041-3045. PubMed ID: 33775997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand.
    Sukmongkolchai S; Petsong S; Oudomying N; Prommi A; Payungporn S; Usawakidwiree W; Wongjarit K; Suwanpimolkul G; Faksri K; Suankratay C; Rotcheewaphan S
    Ann Clin Microbiol Antimicrob; 2023 Sep; 22(1):87. PubMed ID: 37735687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Arghittu M; Girelli D; Biffi A; D'Accico M; Daccò V; Gambazza S; Pizzamiglio G; Trovato A; Tortoli E; Colombo C; Cariani L
    New Microbiol; 2020 Jul; 43(3):127-132. PubMed ID: 32656572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease.
    Im Y; Kim SY; Kim DH; Jhun BW
    Chest; 2024 Feb; 165(2):288-302. PubMed ID: 37661004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of rifabutin against Mycobacterium abscessus, clinical isolates.
    Chen J; Zhang H; Guo Q; He S; Xu L; Zhang Z; Ma J; Chu H
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):767-775. PubMed ID: 35531776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.